Digital Health Accelerators Digital Health Today Ambassadors Digital Health Today Digital Health Today-Resources Digital Health Today Ambassadors

In this episode, we take a break from interviewing entrepreneurs and switch gears to get into a head of one of the investors in the industry, Justin Norden.

Justin is a Partner at GSR Ventures where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health.

In this episode, we cover:

  • The Healthcare Thesis at GSR Ventures
  • Virtual Reality (VR) Digital Therapeutics
  • Stand-alone DTx (biotech-like pipelines) vs. Drug+ DTx
  • What it would take to scale existing Prescription Digital Therapeutics
  • The Role Of Health Coaching alongside AI automation
  • The Drivers of Success Going Forward for the Digital Therapeutics Market

Guest Links and Resources:

  • Connect with Justin Norden on LinkedIn | Twitter
  • Visit https://gsrventuresglobal.com

Host Links:

Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Presenting Partner

Contributing Sponsors

cover
Industry Leaders Weigh in on the Recent Pear Therapeutics News and the Future of Prescription Digital Therapeutics In this special episode of DTx Podcast, Eugene is joined by Brent Vaughan, CEO of Cognito, as well as industry leaders from previous episodes, to weigh in on the recent Pear Therapeutics news and the future of prescription digital therapeutics.